Suppr超能文献

血管加压素拮抗剂诱导大鼠低血压:肥大细胞脱颗粒的作用。

Hypotension induced by vasopressin antagonists in rats: role of mast cell degranulation.

作者信息

Macia R A, Silver A C, Gabel R A, Campbell G K, Hanna N, DiMartino M J

机构信息

Department of Investigative Toxicology, Smith Kline & French Laboratories, King of Prussia, Pennsylvania 19406-0939.

出版信息

Toxicol Appl Pharmacol. 1990 Jan;102(1):117-27. doi: 10.1016/0041-008x(90)90089-d.

Abstract

SK&F 101926, a synthetic peptide, is a potent antagonist of vasopressin at both the V2 and the V1 receptors. Following intravenous administration of SK&F 101926 (5 mg/kg), mean arterial pressure (MAP) immediately fell 75 mm Hg. Heart rate increased approximately 50 beats/min. Cutaneous flushing and cyanosis appeared approximately 2 to 5 min after the SK&F 101926 administration. Three of the five rats died within 40 min with no improvement in either color or MAP. The two surviving animals slowly recovered from these symptoms. The hypotension and flushing recorded in these studies resembled the effects during hypotensive shock. SK&F 101926 degranulated rat peritoneal mast cells in vitro as measured by the liberation of histamine. Analogs of SK&F 101926 were identified having reduced activity to release histamine from mast cells in vitro. The activity of these analogs to release histamine in vivo was also tested, as reflected by rat paw edema. A positive correlation was found between the potency to produce edema in vivo and the potency to release mast cell histamine in vitro (r = 0.94, p less than 0.05). In addition, compounds that released mast cell histamine and induced rat paw edema also produced hypotension and death when administered intravenously, while analogs which produced minimal histamine release in vitro produced minimal or no cardiovascular changes or lethality in vivo at the same dosages (5 mg/kg). Finally, cyproheptadine (10 mg/kg), an antagonist at both the serotonin and the histamine receptors, blunted the effects of SK&F 101926 on MAP and blocked the lethality. Pretreatment with a combination of histamine (H1 and H2) antagonists provided little protection against the SK&F 101926-induced toxicity. These data indicate that the cardiovascular toxicity of SK&F 101926 (and related peptides) is mediated via the release of autocoids from mast cells. Serotonin appears to play a major role in mediating the cardiovascular toxicity of SK&F 101926.

摘要

SK&F 101926是一种合成肽,在V2和V1受体上都是血管加压素的强效拮抗剂。静脉注射SK&F 101926(5毫克/千克)后,平均动脉压(MAP)立即下降75毫米汞柱。心率增加约50次/分钟。给药SK&F 101926后约2至5分钟出现皮肤潮红和发绀。五只大鼠中有三只在40分钟内死亡,肤色和MAP均无改善。两只存活的动物从这些症状中慢慢恢复。这些研究中记录的低血压和潮红类似于低血压休克期间的效应。通过组胺释放测定,SK&F 101926在体外使大鼠腹膜肥大细胞脱颗粒。已鉴定出SK&F 101926的类似物在体外从肥大细胞释放组胺的活性降低。还测试了这些类似物在体内释放组胺的活性,以大鼠爪水肿为指标。发现体内产生水肿的效力与体外释放肥大细胞组胺的效力之间存在正相关(r = 0.94,p小于0.05)。此外,释放肥大细胞组胺并诱导大鼠爪水肿的化合物静脉给药时也会产生低血压和死亡,而在体外产生最小组胺释放的类似物在相同剂量(5毫克/千克)下在体内产生最小或无心血管变化或致死性。最后,赛庚啶(10毫克/千克),一种血清素和组胺受体的拮抗剂,减弱了SK&F 101926对MAP的作用并阻断了致死性。用组胺(H1和H2)拮抗剂联合预处理对SK&F 101926诱导的毒性几乎没有保护作用。这些数据表明SK&F 101926(及相关肽)的心血管毒性是通过肥大细胞释放自体活性物质介导的。血清素似乎在介导SK&F 101926的心血管毒性中起主要作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验